Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

FGEN FibroGen Inc

1,17

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 12:30:12

Verzögert um 15 Minuten

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

FibroGen (NASDAQ:FGEN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more FibroGen Charts.

FibroGen (NASDAQ:FGEN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more FibroGen Charts.

News FibroGen Inc

FibroGen to Report First Quarter 2024 Financial Results
Montag 29 April 2024 (3 Tage vor) • GlobeNewswire Inc.

FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology A
Mittwoch 24 April 2024 (1 Woche vor) • GlobeNewswire Inc.

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
Dienstag 2 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference
Dienstag 26 März 2024 (1 Monat vor) • GlobeNewswire Inc.

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
Montag 11 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 26 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
Montag 26 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZeneca Territories, Except China and South Korea
Montag 26 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 24 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere FibroGen Inc News-Artikel

Energy Select Sector SPDR

Deutsche Telekom

Deutsche Lufthansa

JP Morgan Chase

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen